INTELLECTUAL PROPERTY AND RESULTS Clause Samples

INTELLECTUAL PROPERTY AND RESULTS. 9.1 Seller warrants that Buyer’s (i) purchase, use or sale (in whole or in part) of Goods, or (ii) purchase of Services and use or sale (in whole or in part) of Results, will not infringe third party IPRs. 9.2 Results shall be provided to, and be the exclusive property of, Buyer. Seller assigns with full title guarantee and free from all third party rights, all IPRs and other rights in Results to Buyer. Seller shall do, or procure to be done, all acts Buyer requires to secure the full Contract benefit, including all rights, title and interest in such IPRs and any other rights. Seller shall not transfer or make available Results to any person except Buyer. Buyer may use and transfer Results for any purpose and may create derivative works therefrom.
INTELLECTUAL PROPERTY AND RESULTS. 8.1 Unless expressly agreed otherwise herein Intellectual Property Rights and Results created/generated in the Project shall be governed by the provisions of the Umbrella Documents including Sections 8 and 9 of and Attachment 4 to the Internal Agreement. 8.2 According to Article 30.1 of the FPA, ‘Background’ means any data, know-how or in- formation held by any Party — whatever its form or nature (tangible or intangible), in- cluding any rights such as intellectual property rights — that: (a) is held by the Parties before they entered into this Project Agreement or no later than before the com- mencement of the particular KIC added value activity and (b) is needed to implement the KIC added-value activities in which they participate under the Project or exploit the results thereof. 8.3 The Background and any modifications proposed by a Party pursuant to Clause 9.1.2 of the Internal Agreement and the relevant Access Rights are specified in Schedule 3A hereto, representing the status at the time of this Project Agreement signature. 8.4 Schedule 3A shall form an integral part of this Agreement. 8.5 According to Article 32.1 of the FPA, ‘Results’ means any (tangible or intangible) out- put of the Project such as data, knowledge or information — whatever its form or na- ture, whether it can be protected or not — that is generated in the Project, as well as any rights attached to it, including intellectual property rights. For further details and specific provisions, including agreements deviating from or in addition to the general principles of the Umbrella Documents, if any, are set forth in Schedule 3B hereto. 8.6 Each of the Parties shall (a) notify the Project Coordinator promptly after conceiving or developing during the Project and in the framework of the Project Activities any Result that it considers patentable or subject to any other forms of intellectual property pro- tection as well as any Result with commercial potential, and (b) communicate the full text of any patent application to the Project Coordinator within a reasonable time of its filing, however not later than by the time the filing becomes publicly available. Each Party shall report its disclosure/s in the [annual] reports referred to in Schedule 5A, item 1.
INTELLECTUAL PROPERTY AND RESULTS. 4.1 All rights to any data, information, material and results, and all intellectual properly rights related thereto, made, written, designed or produced by the Employee during the term of this Agreement (the “Results”) shall be vested in and owned by Pharmalink without any further compensation to the Employee than the Base Salary. For the avoidance of doubt, Pharmalink shall without any restrictions have the right to freely develop, alter, license assign and otherwise dispose Results at Pharmalink’s discretion. 4.2 The Employee has no right to directly or indirectly in any way use or exploit the Results during the term of his employment or thereafter unless a written agreement regarding such use has been entered into with Pharmalink. 4.3 The Employee agrees and undertakes without any additional compensation to execute all such deeds and documents that, in Pharmalink’s sole discretion, arc necessary or desirable in order for Pharmalink to be able to protect, register, maintain and in any other way be able to fully enjoy Pharmalink’s rights to Results.
INTELLECTUAL PROPERTY AND RESULTS. 7.1 Intellectual property rights or other results created in the course of the Project shall be owned by the creator(s) of such property rights or other results, i.e. in general company who will host the student during the Internship program or it will be part of special agreement between the Company and student.
INTELLECTUAL PROPERTY AND RESULTS. The Recipient shall own all of the Results and any and all intellectual property rights in relation to the same shall vest solely in and be the property of Recipient. The Recipient will provide Cardiff with Results in such format and at such times as Cardiff may reasonably require. The Recipient accepts that Cardiff may wish to undertake statistical analysis of such Results and shall co-operate in good faith with any reasonable requests or instructions in relation to the same. The Recipient grants to Cardiff a non-exclusive, perpetual, royalty free licence to use all Results provided to Cardiff under this Agreement for Cardiff’s non-commercial academic, teaching and research purposes only. Where appropriate, Cardiff shall acknowledge the contribution of the Recipient in accordance with good academic practice.
INTELLECTUAL PROPERTY AND RESULTS. The Recipient shall own all of the Results and any and all intellectual property rights in relation to the same shall vest solely in and be the property of Recipient. The Recipient will provide NTU MIC with Results in such format and at such times as NTU MIC may reasonably require. The Recipient accepts that NTU MIC may wish to undertake statistical analysis of such Results and shall co-operate in good faith with any reasonable requests or instructions in relation to the same. The Recipient grants to NTU MIC a non-exclusive, perpetual, royalty free license to use all Results provided to NTU MIC under this Agreement for NTU MIC’s non-commercial academic, teaching and research purposes only. Where appropriate, NTU MIC shall acknowledge the contribution of the Recipient in accordance with good academic practice.
INTELLECTUAL PROPERTY AND RESULTS 

Related to INTELLECTUAL PROPERTY AND RESULTS

  • Intellectual Properties To the extent permissible under applicable law, all intellectual properties made or conceived by Employee during the term of this employment by Employer shall be the right and property solely of Employer, whether developed independently by Employee or jointly with others. The Employee will sign the Employer’s standard Employee Innovation, Proprietary Information and Confidentiality Agreement (“Confidentiality Agreement”).

  • Intellectual Property Agreements Borrower shall not permit the inclusion in any material contract to which it becomes a party of any provisions that could or might in any way prevent the creation of a security interest in Borrower's rights and interests in any property included within the definition of the Intellectual Property Collateral acquired under such contracts.

  • Intellectual Property, etc Each of Holdings and each of its Subsidiaries owns or has the right to use all domestic and foreign patents, trademarks, permits, domain names, service marks, trade names, copyrights, licenses, franchises, inventions, trade secrets, proprietary information and know-how of any type, whether or not written (including, but not limited to, rights in computer programs and databases) and formulas, or other rights with respect to the foregoing, and has obtained assignments of all leases, licenses and other rights of whatever nature, in each case necessary for the conduct of its business, without any known conflict with the rights of others which, or the failure to obtain which, as the case may be, individually or in the aggregate, has had, or could reasonably be expected to have, a Material Adverse Effect.

  • INTELLECTUAL PROPERTY RIGHTS - DATA RIGHTS A. Data produced under this Annex which is subject to paragraph C. of the Intellectual Property Rights - Data Rights Article of the Umbrella Agreement will be protected for the period of one year. B. Under paragraph H. of the Intellectual Property Rights - Data Rights Article of the Umbrella Agreement, Disclosing Party provides the following Data to Receiving Party. The lists below may not be comprehensive, are subject to change, and do not supersede any restrictive notice on the Data provided.

  • Assignment of Intellectual Property Rights (a) Executive hereby assigns to Nucor Corporation Executive’s entire right, title and interest, including copyrights and patents, in any idea, invention, design of a useful article (whether the design is ornamental or otherwise), work product and any other work of authorship (collectively the “Developments”), made or conceived solely or jointly by Executive at any time during Executive’s employment by Nucor (whether prior or subsequent to the execution of this Agreement), or created wholly or in part by Executive, whether or not such Developments are patentable, copyrightable or susceptible to other forms of protection, where the Developments: (i) were developed, invented, or conceived within the scope of Executive’s employment with Nucor; (ii) relate to Nucor’s actual or demonstrably anticipated research or development; or (iii) result from any work performed by Executive on Nucor’s behalf. Executive shall disclose any Developments to Nucor’s management within 30 days following Executive’s development, making or conception thereof. (b) The assignment requirement in Section 15(a) shall not apply to an invention that Executive developed entirely on Executive’s own time without using Nucor’s equipment, supplies, facilities or Secret Information or Confidential Information except for those inventions that (i) relate to Nucor’s business or actual or demonstrably anticipated research or development, or (ii) result from any work performed by Executive for Nucor. (c) Executive will, within 3 business days following Nucor’s request, execute a specific assignment of title to any Developments to Nucor Corporation or its designee, and do anything else reasonably necessary to enable Nucor Corporation or its designee to secure a patent, copyright, or other form of protection for any Developments in the United States and in any other applicable country. (d) Nothing in this Section 15 is intended to waive, or shall be construed as waiving, any assignment of any Developments to Nucor implied by law.